GENEVA OS
LIVE

Serial Number

98182304

Owner

Atropos Health, Inc.

Attorney

Thomas Y. Yee

First Use Date

Oct 5, 2023

Filing Date

Sep 15, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GENEVA OS Trademark

Serial Number: 98182304 • Registration: 7771675

GENEVA OS is a trademark filed by Atropos Health, Inc. on September 15, 2023. The trademark is classified under Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Atropos Health, Inc. (20 trademarks)

169 Madison Avenue, Unit 2242
New York, NY 10016

Entity Type: 03

Trademark Details

Filing Date

September 15, 2023

Registration Date

April 22, 2025

First Use Anywhere

October 5, 2023

First Use in Commerce

October 5, 2023

Published for Opposition

May 21, 2024

Goods & Services

Providing access to an electronic exchange of health data and data analyses across an integrated nationwide clinical research network; transmission of health and medical record and life science report and article database information and analyses of health and medical record and life science report and articles database information via telecommunications networks; electronic exchange of health data and life science report and articles insights via telecommunication networks for analyses of health data from clinicians, health systems, academic medical centers, life sciences companies, and others; electronic transmission of health data; all of the foregoing services may also be provided by means of artificial intelligence

Business consulting and data management in the field of clinical trials, namely, providing information management services by means of data compilation; collection, reporting, and analysis of healthcare records, clinical records, and life science report and article-related data for business purposes; services consisting of the registration, collection, transcription, compilation, clarification, enablement, enhancement, management, mapping, and systemization of written communications and data; all of the foregoing services may also be provided by means of artificial intelligence

Providing medical information to healthcare providers and healthcare professionals, and life sciences companies to help them make informed decisions for patient diagnosis and treatment and clinical trial design, emulation, strategy, and prioritization; providing health data analysis to healthcare providers and healthcare professionals in the medical and patient-care industry to help them to assess clinical data for the purpose of patient diagnosis and treatment and improving quality of care in the medical and healthcare industry; providing information and data related to patient data, namely, demographics, diagnoses, procedures, medications, laboratory values, clinical notes, mortality, and length of stay information for patients to inform clinical care decisions and research and to inform life science company corporate strategy, research and development, and marketing and brand planning; providing on-line medical and clinical record and life science articles and reports analysis services designed to provide healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; providing on-line medical and clinical record and life science articles and reports analysis services designed to provide medical providers with custom tailored information about the outcomes for patients with similar symptoms and evidence needed for patient care decisions; compiling, clarifying, enabling, enhancing, managing, mapping and analyzing medical and clinical data and life science articles and reports for medical treatment purposes; all of the foregoing services may also be provided by means of artificial intelligence

Providing medical, health, and scientific research information, research data, and research services to assist healthcare providers, healthcare professionals, and life sciences companies in making informed decisions for patient diagnosis and treatment and clinical trial design, emulation, strategy, and prioritization; collecting, storing, indexing, analyzing, updating, managing, sharing, and reporting real world data to create actionable insights for use by healthcare providers, healthcare professionals, and life sciences companies; providing medical and scientific research information in the field of clinical trials and life sciences; compiling data for research purposes in the field of medical science and medical consultancy and life sciences; software as a service (SAAS) services featuring software for providing diagnosis and treatments recommendations for physicians and researchers; software as a service (SAAS) services featuring software for collecting, storing, indexing, analyzing, updating, managing, sharing, clarifying, enabling, enhancing, managing, mapping and reporting clinical trial, data, electronic health records, claims data, life science articles and report, and medical research data to evaluate and recommend medical diagnoses and treatments; software as a service (SAAS) services featuring software for searching, organizing and managing data, namely, demographics, diagnoses, procedures, medications, laboratory values, clinical notes, mortality, and length of stay information for patients to inform clinical care decisions and research; software as a service (SAAS) services featuring software for providing healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; software as a service (SAAS) services featuring software for compiling, clarifying, enabling, enhancing, managing, mapping, and analyzing medical records and heath data and life science articles and reports; software as a service (SAAS) services featuring software using a natural language or large language model, artificial intelligence, and machine learning for compiling, clarifying, enabling, enhancing, managing, mapping and analyzing medical records and heath data and life science articles and reports; software as a service (SAAS) services featuring chatbot software using a natural language or large language model or artificial intelligence for compiling, clarifying, enabling, enhancing, managing, mapping, and analyzing medical records and heath data and life science articles and reports and providing tailored reports regarding the data to physicians and researchers; compiling data for research purposes in the field of medical science and medical consultancy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 22, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 22, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 1, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 1, 2025 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 7, 2025 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Mar 6, 2025 SUPC
SOU EXTENSION 1 GRANTED
Mar 6, 2025 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 5, 2025 AITU
USE AMENDMENT FILED
Dec 24, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 24, 2024 EISU
SOU EXTENSION 1 FILED
Dec 20, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 20, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 16, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 3, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 3, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 3, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 18, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2023 NWOS
NEW APPLICATION ENTERED
Sep 19, 2023 NWAP